LISATA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
LSTA$1.02-8.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 202 and
Index
(In thousands, except share data)
| December 31,2023 | December 31,2022 | |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $22,593 | $32,154 |
| Marketable securities | 27,942 | 37,072 |
| Prepaid and other current assets | 3,389 | 2,650 |
| Total current assets | 53,924 | 71,876 |
| Property and equipment, net | 175 | 296 |
| Acquired license-intangible, net | 263 | 334 |
| Other assets | 332 | 528 |
| Total assets | $54,694 | $73,034 |
| LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY | ||
| Liabilities | ||
| Accounts payable | $2,421 | $2,655 |
| Accrued liabilities | 4,169 | 3,728 |
| Total current liabilities | 6,590 | 6,383 |
| Other long-term liabilities | 210 | 327 |
| Total liabilities | 6,800 | 6,710 |
| Commitments and Contingencies (Note 14) | ||
| Stockholders' Equity | ||
| Common stock, $0.001 par value, authorized 33,333,333 shares; issued 8,150,635 and 7,866,799 shares, at December 31, 2023 and December 31, 2022, respectively; and outstanding, 8,149,897 and 7,866,061 shares, at December 31, 2023 and December 31, 2022, respectively | 8 | 8 |
| Additional paid-in capital | 576,971 | 574,548 |
| Treasury stock, at cost; 738 shares at December 31, 2023 and December 31, 2022 respectively | (708) | (708) |
| Accumulated deficit | (528,081) | (507,241) |
| Accumulated other comprehensive loss | (42) | (29) |
| Total Lisata Therapeutics, Inc. stockholders' equity | 48,148 | 66,578 |
| Non-controlling interests | (254) | (254) |
| Total equity | 47,894 | 66,324 |
| Total liabilities, non-controlling interests and stockholders' equity | $54,694 | $73,034 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.